3P Biopharmaceuticals incorpora a Keensight Capital como accionista mayoritario

by 3PBIOVIAN

7 years ago
accionista, inversión, 3P Biopharmaceuticals, Keensight Capital

3P Biopharmaceuticals (3P), compañía especializada en el desarrollo de procesos y fabricación GMP de productos biológicos (CDMO) anuncia la incorporación de Keensight Capital, una de las principa...

3P Biopharmaceuticals y Nordic Nanovector amplían su colaboración para la fabricación en etapa avanzada de Betalutin®, el tratamiento para el linfoma no Hodgkin (LNH) de células B

by 3PBIOVIAN

7 years ago
3P Biopharmaceuticals, Nordic Nanovector, colaboración, Betalutin, LNH

El LNH es un cáncer que comienza en los glóbulos blancos, llamados linfocitos, y que forman parte del sistema inmunitario

3P Biopharmaceuticals firma un acuerdo de fabricación con la empresa sueca Affibody para el tratamiento de la psoriasis

by 3PBIOVIAN

7 years ago
3P Biopharmaceuticals, Affibody, fabricación GMP, tratamiento de la psoriasis

El acuerdo cubre la transferencia y el desarrollo de proceso, así como la fabricación GMP del medicamento candidato de Affibody

3P Biopharmaceuticals e Intervacc afianzan su colaboración con la fabricación a gran escala de Strangvac®

by 3PBIOVIAN

7 years ago
paperas, Strangvac, Intervacc, 3P Biopharmaceuticals

3P Biopharmaceuticals y la compañía sueca Intervacc, confirman la producción a gran escala de Strangvac®, la vacuna contra las paperas equinas en la que llevan tiempo colaborando.

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

by 3PBIOVIAN

7 years ago
3P Biopharmaceuticals, contract, collaboration, Xenikos, T-Guard, transplant

3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xeni...

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

by 3PBIOVIAN

8 years ago
facilities, 3P Biopharmaceuticals, bioprocesses, manufacturing plant, Robustness

3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months. The investment exceed...

3P Biopharmaceuticals and Viscofan to collaborate in an innovate advanced therapy project

by 3PBIOVIAN

8 years ago
Cardiomesh, cell therapy product, GMP manufacturing

Cardiomesh is the project in which 3P Biopharmaceuticals and Viscofan are collaborating to develop and manufacture an innovative cell therapy product. 3P Biopharmaceuticals has executed the tuning, th...

3P Biopharmaceuticals incorporates a LIMS, a Laboratory Information Management Systems

by 3PBIOVIAN

8 years ago
LIMS, 3P Biopharmaceuticals

This acquisition has involved an investment of approximately 200.000 € (system, implementation and associated services) and it is part of an investment plan that 3P is conducting during 2018 with th...

3P Biopharmaceuticals is proud to announce a new collaboration agreement signed with the Swedish company Intervacc

by 3PBIOVIAN

9 years ago
Intervacc, vaccine, 3P Biopharmaceuticals

Intervacc has signed a Letter of Intent and an agreement on first mile stones with 3P Biopharmaceuticals in Pamplona, Spain, for contract manufacturing of Strangvac®, Intervacc´s recombinant vaccine...

3P Biopharmaceuticals reunió a más de 150 invitados en su décimo aniversario

by 3PBIOVIAN

9 years ago
3P Biopharmaceuticals

3P Biopharmaceuticals es una compañía biotecnológica CDMO (Contract Development Manufacturing Organization) especializada en el desarrollo de procesos y fabricación GMP de medicamentos biológicos...

How to select the perfect partner, next CPhI 2015 by 3PBiopharmaceuticals, Charles River, Covance and Menarini Biotech

by 3PBIOVIAN

11 years ago
round table, CPhI, Covance, Charles River, Menarini Biotech, ASEBIO, 3P Biopharmaceuticals

"The challenge of Partner selection: the best travel companion in biologics drug development adventure” will discover the keys to success in this major challenge

3P Biopharmaceuticals Advanced Therapy area develops a GMP buffer involved in a novel treatment for the Age-Related Macular Degeneration (AMD)

by 3PBIOVIAN

11 years ago
TargetAMD, neovascularisation, Age-related Macular Degeneration

The project has received funding from the European Union’s Seventh Framework Programme and aims to develop a non-viral gene therapeutic approach for the treatment of this neurodegenerative disease o...